The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNEX.L Regulatory News (NEX)

  • There is currently no data for NEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Mar 2023 16:32

RNS Number : 4189T
National Express Group PLC
17 March 2023
 

 

NATIONAL EXPRESS GROUP PLC

 (the "Company")

 

Director/PDMR Shareholding

 

The Company provides notification of the following transactions, all effected on 17 March 2023, relating to the below named PDMR and his interests in the ordinary shares of nominal value 5p each in the capital of the Company ("Shares") (ISIN: GB0006215205).

 

The transactions arise in respect of:

 

i. the vesting of 86,315 forfeitable Shares awarded to Ignacio Garat on 17 March 2022 under the rules of the Company's Executive Deferred Bonus Plan ("EDBP") in relation to the deferred element of his 2021 annual bonus; and

ii. the immediate sale of a sufficient number of such Shares to cover tax, social security and dealing cost liabilities arising on that vest.

 

Individual PDMR details are set out in the table below:

 

Name and position of PDMR

Number of forfeitable Shares vested and sold as per above ¹ ² ³

Total unrestricted beneficial interest held in Shares following the transactions ⁴

 

Total other

interest held in

Shares following the transactions ⁵

Ignacio Garat, Chief Executive Officer

86,315 vested of which 40,651 were sold to cover tax and dealing costs

107,204

845,312

¹ The Shares sold comprise those compulsorily sold to cover the immediate income tax, social security and dealing cost liabilities arising on vesting of the 2022 EDBP award.

² All Shares delivered to the individual are existing Shares delivered through the Company's Employee Benefit Trust.

³ Malus and clawback will apply to the forfeitable Shares vested in the 2022 EDBP Award for two-years from the date of vest, including post termination of employment.

⁴ Including those held by the PDMR's connected persons.

⁵ Represents outstanding awards granted under the Company's EDBP and Long-Term Incentive Plan.

 

 

1.

Details of PDMR / PCA

Full Name

Ignacio Garat

Position / status

Group Chief Executive Officer, PDMR

Initial notification / amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

 

Name

National Express Group PLC

LEI

213800A8IQEMY8PA5X34

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument

 

Ordinary shares of 5p each

 

 

 

 

Identification code

GB0006215205

 

Nature of the transaction

1. Vest of 2022 share award under the National Express Group PLC (the "Company") Executive Deferred Bonus Plan ("EDBP"); and

2. Sale of sufficient shares from the 2022 share award under the Company's EDBP to cover tax, social security and dealing cost liabilities.

Price(s) and volume(s)

Price(s)

Volume(s)

Total

1.

£ n/a

86,315

£0.00

2.

£1.200065

40,651

£48,783.84

Aggregated

126,966

£48,783.84

Date of the transaction

17 March 2023

Place of the transaction

(i) Off market

(ii) London Stock Exchange

 

The above notice is given in fulfilment of the Company's obligation under DTR 3.1 and Article 19 of the EU Market Abuse Regulation 596/2014.

 

- END -

 

National Express contacts and telephone number for enquiries:

 

Simon Callander, Group General Counsel & Company Secretary

+44 (0) 7795 232 708

 

Gillian Saunderson, Deputy Company Secretary

+44 (0) 7506 642 348

 

Notes:

Legal Entity Identifier: 213800A8IQEMY8PA5X34

Classification: 3.1 (with reference to DTR6 Annex 1R)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKOBNABKDDND
Date   Source Headline
20th Jun 202311:21 amRNSChange of Name
16th Jun 20232:51 pmRNSHolding(s) in Company
14th Jun 20239:02 amRNSHolding(s) in Company
2nd Jun 20237:00 amRNSDirector/PDMR Shareholding
10th May 20234:11 pmRNSResult of AGM
10th May 20237:00 amRNSChange of Name
19th Apr 20237:00 amRNSQ1 Trading Update
14th Apr 202312:43 pmRNSHolding(s) in Company
3rd Apr 20239:16 amRNSTotal Voting Rights
30th Mar 20233:54 pmRNSHolding(s) in Company
30th Mar 20231:21 pmRNSHolding(s) in Company
30th Mar 20231:17 pmRNSHolding(s) in Company
28th Mar 20234:33 pmRNSHolding(s) in Company
28th Mar 20232:11 pmRNSDirector/PDMR Shareholding
27th Mar 20235:34 pmRNSHolding(s) in Company
27th Mar 202310:12 amRNS2022 Annual Report and Notice of 2023 AGM
20th Mar 20234:52 pmRNSHolding(s) in Company
17th Mar 20234:32 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
9th Feb 20237:00 amRNSNotice of FY22 Results Presentation
23rd Jan 20237:00 amRNSEUR1 Billion German Rail Contract Award
3rd Jan 202311:02 amRNSTotal Voting Rights
5th Dec 20227:00 amRNSAPPOINTMENT OF GROUP CFO
20th Oct 20227:00 amRNSTrading Statement
3rd Oct 20229:15 amRNSDirector/PDMR Shareholding
3rd Oct 20229:11 amRNSTotal Voting Rights
8th Sep 20227:01 amRNSAPPOINTMENT OF INTERIM GROUP CFO
8th Sep 20227:00 amRNSAPPOINTMENT OF CHAIR DESIGNATE
5th Sep 20224:22 pmRNSDirector/PDMR Shareholding
15th Aug 202212:54 pmRNSDirector/PDMR Shareholding
10th Aug 20227:04 amRNSDirectorate Change
4th Aug 20223:27 pmRNSHolding(s) in Company
1st Aug 202211:32 amRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNSHalf-year Report
1st Jul 20228:31 amRNSTotal Voting Rights
28th Jun 20221:01 pmRNSHolding(s) in Company
23rd Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:43 pmRNSPublication of a Prospectus
10th Jun 20223:43 pmRNSDirector/PDMR Shareholding
9th Jun 20223:16 pmRNSHolding(s) in Company
7th Jun 20227:00 amRNSTrading Statement
24th May 20221:56 pmRNSForm 8.3 - Stagecoach Group plc
24th May 20221:48 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:52 pmRNSForm 8.3 - STAGECOACH GROUP PLC
23rd May 20223:49 pmRNSForm 8.3 - National Express Group plc
23rd May 20223:31 pmRNSForm 8.3 -National Express Group plc
23rd May 20223:20 pmRNSForm 8.3 - National Express Group plc
23rd May 20221:51 pmGNWForm 8.3 - National Express Group PLC
23rd May 20221:29 pmRNSForm 8.3 - National Express Group Plc
23rd May 202211:35 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - National Express Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.